Replies to post #226965 on Biotech Values

[miljenko]

Yes, but there is some difference in sub-receptor. Xanomeline is M1,M4 agonist and M5 antagonist, while trospium is M1,M2&M3 antagonist. So, there is still possibility for on-target toxicity. Data to good to be true?????